Nuvaira Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $36.7M

  • Investors
  • 14

Nuvaira General Information

Description

Developer of a medical device designed to improve outcomes for patients suffering from obstructive lung diseases. The company's device is a novel, catheter-based system to treat overactive airway nerves, a common disease feature of both COPD and asthma, enabling physicians to reduce the clinical consequences of neural hyperactivity.

Contact Information

Website
www.nuvaira.com
Formerly Known As
Innovative Pulmonary Solutions, Holaira
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6500 Wedgwood Road North
  • Suite 100
  • Maple Grove, MN 55311
  • United States
+1 (763)
Primary Industry
Surgical Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
HealthTech
Corporate Office
  • 6500 Wedgwood Road North
  • Suite 100
  • Maple Grove, MN 55311
  • United States
+1 (763)

Nuvaira Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nuvaira Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 04-Mar-2026 $36.7M Completed Clinical Trials - Phase 3
9. Later Stage VC 09-May-2024 Completed Clinical Trials - Phase 3
8. Later Stage VC (Series F) 30-Nov-2023 Completed Clinical Trials - Phase 3
7. Debt - General 01-Dec-2021 Completed Clinical Trials - Phase 3
6. Later Stage VC (Series E) 11-Feb-2019 Completed Clinical Trials - Phase 3
5. Later Stage VC (Series D) 03-Apr-2014 Completed Startup
4. Later Stage VC (Series C) 11-Feb-2013 Completed Startup
3. Early Stage VC (Series B) 20-Sep-2012 Completed Startup
2. Early Stage VC (Series A) 29-Sep-2010 $8.24M $8.24M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Nuvaira’s complete valuation and funding history, request access »

Nuvaira Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series F
Series E2-1
Series E2
Series E1-1
Series E1
Series D-1
Series D
Series C-1
Series C 5,488,775 $0.000100 8% $0.02 $0.02 $0.02 0%
Series B-1 6,550,750,000 $0.000001 8% $0 $0 1x $0 2.58%
To view Nuvaira’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Nuvaira Patents

  • 232

    Total Documents Applications and Grants

  • Total Patents Families

  • 152

    Granted

  • 24

    Pending

  • Expiring in next 12 mo

Nuvaira Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024371167-A1 Device and method for esophageal protection Pending 31-Oct-2023
EP-4801400-A1 Device and method for esophageal protection Pending 31-Oct-2023
WO-2025096847-A1 Device and method for esophageal protection Inactive 31-Oct-2023
EP-4622702-A1 Attachment mechanism for medical device Pending 23-Nov-2022
US-12539030-B2 Attachment mechanism for medical device Active 23-Nov-2022 A61B1/2676
To view Nuvaira’s complete patent history, request access »

Nuvaira Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nuvaira Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Endeavour Vision Venture Capital Minority
Qiming Venture Partners USA Venture Capital Minority
Richard King Mellon Foundation Limited Partner Minority
U.S. Venture Partners Venture Capital Minority
Vensana Capital Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Nuvaira FAQs

  • When was Nuvaira founded?

    Nuvaira was founded in 2008.

  • Where is Nuvaira headquartered?

    Nuvaira is headquartered in Maple Grove, MN.

  • What is the size of Nuvaira?

    Nuvaira has 35 total employees.

  • What industry is Nuvaira in?

    Nuvaira’s primary industry is Surgical Devices.

  • Is Nuvaira a private or public company?

    Nuvaira is a Private company.

  • What is Nuvaira’s current revenue?

    The current revenue for Nuvaira is .

  • How much funding has Nuvaira raised over time?

    Nuvaira has raised $244M.

  • Who are Nuvaira’s investors?

    Endeavour Vision, Qiming Venture Partners USA, Richard King Mellon Foundation, U.S. Venture Partners, and Vensana Capital are 5 of 14 investors who have invested in Nuvaira.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process